Insulet Profit Margin 2007-2018 | PODD
Current and historical gross margin, operating margin and net profit margin for Insulet (PODD) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Insulet net profit margin as of December 31, 2018 is 0.58%.
|Insulet Annual Profit Margins
|Insulet Quarterly Profit Margins
||Medical Products Manufacturing
INSULET CORPORATION is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use components with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of continuous subcutaneous insulin infusion (CSII) therapy among people with insulin-dependent diabetes.